Home
BÀI TỔNG QUAN.
Issue: Số 93, 2021
Article
Nguyễn Thiên Vũ: Trường Đại học Y Dược Cần Thơ;
Trương Văn Hòa: Trường Đại học Y Dược Cần Thơ;
Nguyễn Thắng: Bộ môn Dược lý – Dược lâm sàng, Trường Đại học Y Dược Cần Thơ;
Nguyễn Hương Thảo: Bộ môn Dược lâm sàng, Đại học Y Dược Thành phố Hồ Chí Minh;
Huỳnh Văn Minh: Trường Đại học Y Dược Huế;
Phạm Thành Suôl: Trường Đại học Y Dược Cần Thơ;
Published: May 1, 2021
Views: 242
References
1.
1. Su M.; Haldane V.; Upshur R., The Impact of Treatment Adherence for Patients With Diabetes and Hypertension on Cardiovascular Disease Risk: Protocol for a Retrospective Cohort Study, 2008-2018. JMIR Res Protoc. 2019 May 31;8(5):e13571
2.
2. Mohammed Awais Hameed, MB, ChB1, 2 and Indranil Dasgupta, DM. Medication adherence and treatment-resistant hypertension: a review. Drugs Context. 2019; 8: 212560. Published online 2019 Feb 4.
3.
3. Burnier M., Egan BM. Adherence in Hypertension. A Review of Prevalence, Risk Factors, Impact, and Management.
4.
4. Burnier M. Monitoring of drug adherence in hypertension.
5.
5. Kronish IM., MPH and Ye S., Adherence to Cardiovascular Medications: Lessons Learned and Future Directions. Prog Cardiovasc Dis. 2013; 55(6): 590–600.
6.
6. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan; 24(1):67-74.
7.
7. Kubica A, Kosobucka A, Michalski P et al. Self-reported questionnaires for assessment adherence to treatment in patients with cardiovascular diseases. Medical Research Journal 2017; 2(4):115-122.
8.
8. Lam WY and Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015; 2015: 217047.
9.
9. Yan J, You LM, Yang Q et al. Translation and validation of a Chinese version of the 8-item Morisky medication adherence scale in myocardial infarction patients. J Eval Clin Pract. 2014 Aug;20(4):311-7.
10.
10. Toll BA, McKee SA, Martin DJ. Factor structure and validity of the Medication Adherence Questionnaire (MAQ)withcigarettesmokerstryingtoquit. Nicotine Tob Res. 2007 May; 9(5): 597–605.
11.
11. Marcum ZA, Zheng Y, Perera Setal. PrevalenceandCorrelatesof Self-Reported Medication NonAdherence among Older Adults with Coronary Heart Disease, Diabetes Mellitus, and/or Hypertension. Res Social Adm Pharm. 2013; 9(6).
12.
12. http://timmachhoc.vn/su-tuan-tri-do-an-toan-do-dung-nap-va-hieu-qua-cua-vien-phoi-hop-lieu- co-dinh-peridopril-amlodipin-o-benh-nhan-hy-lap-co-tang-huyet-ap-va-benh-mach-vanh-on-dinh- mot-nghien-cuu-quan-sat-tien-cuu-tren-t/
13.
13. Mannapperuma U, Galappatthy P, Silva VA. ValidationoftheSinhalaversionoftheMoriskyMedicationAdherence Scale to determine medication adherence in patients with bipolar affective disorder on lithium therapy.
14.
14. Donald E Morisky, M Robin DiMatteo. Improving the measurement of self-reported medication nonadherence: Response to Authors. Journal of clinical epidemiology 64(3):255-7.
15.
15. Risser J, Jacobson TA, Kripalani S. Development and Psychometric Evaluation of the Self-Efficacy for Appropriate Medication Use Scale (SEAMS) in Low-Literacy Patients With Chronic Disease. Journal of Nursing Measurement, Volume 15, Number 3, 2007.
16.
16. Naqvi A. A., Hassali M. A., Rizvi M. et al. (2018), “Development and validation of a novel General Medication Adherence Scale (GMAS) for chronic illness patients in Pakistan”, Frontiers in pharmacology. 9, 1124.
17.
17. Naqvi A. A., Hassali M. A., Jahangir A. et al. (2019), “Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses”, Journal of Drug Assessment. 8 (1), 36-42.
18.
18. Naqvi A. A., Al-Shayban D. M., Ghori S. A. et al. (2019), “Validation of the General Medication Adherence Scale (GMAS) in Saudi patients with chronic disease”, Frontiers in pharmacology. 10, 633.
19.
19. Thang Nguyen, Thao H Nguyen, Suol T Pham, et al. Translation and Cross-Cultural Adaptation of the Brief Illness Perception Questionnaire, the Beliefs About Medicines Questionnaire and the Morisky Medication Adherence Scale Into Vietnamese.